SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

India Globalization Capital, Inc. – ‘8-K’ for 10/15/21

On:  Friday, 10/15/21, at 4:46pm ET   ·   For:  10/15/21   ·   Accession #:  1185185-21-1484   ·   File #:  1-32830

Previous ‘8-K’:  ‘8-K’ on 1/14/21 for 1/11/21   ·   Next:  ‘8-K’ on 11/19/21 for 11/18/21   ·   Latest:  ‘8-K’ on 4/5/24 for 3/20/24   ·   1 Reference:  By:  IGC Pharma, Inc. – ‘S-8’ on 12/23/21

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/15/21  India Globalization Capital, Inc. 8-K:5,8,9  10/15/21   12:188K                                   Federal Filings, LLC/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     33K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML      8K 
 8: R1          Document And Entity Information                     HTML     46K 
10: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- indiaglob20211015_8k_htm            XML     13K 
 9: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 4: EX-101.DEF  XBRL Definitions -- igc-20211015_def                 XML     33K 
 5: EX-101.LAB  XBRL Labels -- igc-20211015_lab                      XML     63K 
 6: EX-101.PRE  XBRL Presentations -- igc-20211015_pre               XML     32K 
 3: EX-101.SCH  XBRL Schema -- igc-20211015                          XSD     13K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    19K 
12: ZIP         XBRL Zipped Folder -- 0001185185-21-001484-xbrl      Zip     17K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C:   C: 


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM  i 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  i October 15, 2021

indiaglob20211015_8kimg001.gif

 

 i INDIA GLOBALIZATION CAPITAL, INC.

(Exact name of registrant as specified in charter)

 

 i Maryland

 i 001-32830

 i 20-2760393

(State or other jurisdiction of incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

 

 i 4336 Montgomery Ave.,  i Bethesda,  i Maryland  i 20814

(Address of principal executive offices)    (Zip Code)

 

 i (301)  i 983-0998

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 i  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 i  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 i  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 i  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

 i Common Stock, $.0001 par value

 i IGC

 i NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1934 (§240.12b-2 of this chapter)

 

Emerging growth company  i .

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On October 15, 2021, Richard Prins was elected to India Globalization Capital’s (the “Company”) Board of Directors at the Annual Meeting, to serve as a Class B director, until the 2024 Annual Meeting of stockholders, and until his respective successor shall be duly elected and qualified, or until his earlier death, resignation or removal from office.

 

Item 5.07.

Submission of Matters to a Vote of Security Holders.

 

On October 15, 2021, at the Annual Meeting, the Company’s shareholders (i) elected Richard Prins to the Company’s Board of Directors to serve as a Class B director, until the 2024 Annual Meeting of stockholders; (ii) ratified the appointment of Manohar Chowdhry & Associates as the Company’s independent registered public accounting firm for the 2022 fiscal year; (iii) approved the grant of 3,500,000 shares of common stock to be granted from time to time to the Company’s current and new employees, advisors, directors, and consultants by the board of directors, pursuant to certain metrics including performance, vesting, and incentive as set by the board of directors and or the CEO; and (iv) approved to adjourn or postpone the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies. 

 

The total number of shares of the Company’s common stock voted in person or by proxy at the 2021 Annual Meeting was 37,257,143 shares, representing approximately 73% of the 51,038,017 shares outstanding and entitled to vote at the Annual Meeting. We received a total of 21,876,265 Broker Non-votes. The director nominee was elected and each other matter submitted to a vote of the Company’s shareholders at the Annual Meeting was approved by the requisite vote. The final voting results for each proposal that passed are set forth below.

 

1.

Election of Directors.

 

Nominee

 

For

   

Withhold

 

Richard Prins

    14,043,542       1,337,336  

 

2.

Proposal to ratify the appointment of Manohar Chowdhry & Associates as the Company’s independent registered public accounting firm for the 2022 fiscal year.

 

For

   

Against

   

Abstain

 
  37,054,636       112,381       90,126  

 

3.

Approval of the grant of 3,500,000 shares of common stock to be granted from time to time to the Company’s current and new employees, advisors, directors, and consultants by the board of directors, pursuant to certain metrics including performance, vesting, and incentive as set by the board of directors and or the CEO.

 

For

   

Against

   

Abstain

 
  14,642,962       665,359       72,557  

 

4.

The proposal to adjourn the meeting to a later date was not necessary or appropriate because there were sufficient votes to approve the other two proposals. 

 

Item 8.01.

Other Events.

 

On October 15, 2021, India Globalization Capital held its 2021 Annual Meeting of Stockholders (the “Annual Meeting”), as previously scheduled. All the Proposals passed.

 

A copy of the press release announcing the results of the Annual Meeting voting is attached hereto as Exhibit 99.1.

 

Item 9.01.

Financial Statements and Exhibits.

 

(d)           Exhibits.

 

Exhibit No.

Description

 
     

99.1

Press Release dated October 15, 2021.

 

104

Cover Page Interactive Data File (formatted as Inline XBRL)   

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

INDIA GLOBALIZATION CAPITAL, INC.

 
     
       

Dated:  October 15, 2021

By:

/s/ Ram Mukunda

 
   

Name: Ram Mukunda

 
   

Title: Chief Executive Officer and President

 
       

 

 

 

 

 
 i false  i 0001326205 0001326205 2021-10-15 2021-10-15

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:10/15/21DEF 14A
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/23/21  IGC Pharma, Inc.                  S-8        12/23/21    5:335K                                   Federal Filings, LLC/FA
Top
Filing Submission 0001185185-21-001484   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 8, 5:51:33.1pm ET